Navigation Links
Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
Date:5/11/2009

Real-time PCR test validated using clinical specimens confirmed

positive for Influenza A H1N1 Swine-origin flu virus

MADISON, N.J., May 11 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Focus Diagnostics infectious disease reference laboratory has introduced a laboratory-developed real-time polymerase chain reaction (PCR) test to aid in identifying Influenza A H1N1 Swine-origin (H1N1) flu virus ("S-OIV" or "novel H1N1"), also known as the Swine Flu. The Focus Diagnostics Influenza A H1N1 (Swine Flu) RNA Real-Time RT-PCR Test is the first laboratory testing service to be introduced by a commercial laboratory to aid in the identification of patients infected with the novel H1N1 virus and differentiate patients infected with other seasonal Influenza A strains. Focus Diagnostics has a track record of being first to market with new laboratory testing services for emerging infectious diseases, such as West Nile Virus, SARS, and chikungunya virus.

"Our new laboratory test will be an important tool to help health care professionals and public health authorities identify infected patients more quickly, promoting earlier diagnosis and treatment," said Jon R. Cohen, M.D., senior vice president and chief medical officer, Quest Diagnostics. "This capability could be particularly important if the novel H1N1 virus continues to spread in the U.S. or re-emerges this fall or winter. Public health officials in the U.S. have done an exceptional job of managing the current Influenza emergency, and we continue to work closely with them to assist their preparedness efforts."

Focus Diagnostics validated its new Influenza A H1N1 (Swine Flu) RNA Real-Time RT-PCR Test using clinical specimens submitt
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
2. Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State
3. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
4. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
5. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
6. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
7. Previous Claims of siRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
8. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
9. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
10. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
11. Colorado Cancer Research Program Will Host Golf Event to Drive the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... 13, 2014 Auf ... Tokio veranstalteten F&E-Tagung meldete Astellas ... Neuausrichtung seines Forschungsrahmenprogramms. Die Tagung bot Astellas ... fortgeschrittenen klinischen Programme und die Konzernstrategie des ... bestand darin, aktuelle Meldungen zu den Astellas-Initiativen ...
(Date:7/13/2014)... 2014  Eli Lilly and Company (NYSE: ... non-clinical study in genetically engineered mice examining combination ... antibody N3pG and beta-secretase inhibitor BACE (LY2811376). Data ... in removing clumps of amyloid-beta protein in the ... lead to Alzheimer,s disease (AD) – than use ...
(Date:7/11/2014)... ANGELES , July 11, 2014 /PRNewswire-iReach/ -- ... e-liquid, a vegetable-glycol solution for use in portable ... of the active ingredients in cannabis, cannabidiol offers ... personal vaporizer devices, and other vaporizer technology. ... Cannabis naturally contains 483 different compounds which ...
Breaking Medicine Technology:Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 2Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 3Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 4New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2
... Neurocrine Biosciences,Inc. (Nasdaq: NBIX ) today announced its financial ... quarter of 2008, the Company reported a,net loss of $21.1 ... of,$25.7 million, or $(0.68) per share, for the same period ... were $1.8 million compared with,$0.1 million for the same period ...
... April 30 CureDM, Inc., a,biopharmaceutical company developing ... 1 and 2 diabetes, announces its,achievement of a ... CureDM has successfully stabilized HIP to improve its,bioavailability ... used in man may be as much as ...
Cached Medicine Technology:Neurocrine Biosciences Reports First Quarter 2008 Results 2Neurocrine Biosciences Reports First Quarter 2008 Results 3Neurocrine Biosciences Reports First Quarter 2008 Results 4Neurocrine Biosciences Reports First Quarter 2008 Results 5Neurocrine Biosciences Reports First Quarter 2008 Results 6Neurocrine Biosciences Reports First Quarter 2008 Results 7Neurocrine Biosciences Reports First Quarter 2008 Results 8CureDM's Diabetes Therapy Achieves Major Development Milestone 2
(Date:7/13/2014)... 13, 2014 Intraocular Lens (IOL) Market: ... 2013 - 2019 , Intraocular lens (IOL) is inserted ... or cataracts. The lenses are inserted inside the eye, ... intraocular lens replaces the focusing power of natural lens. ... lens to deliver the light focusing function which was ...
(Date:7/13/2014)... 13, 2014 Victorian Hotel has recently ... the rental of bikes for its "Cycle the City" ... Hotel to tour the area using a rental bicycle, ... enthusiasts love to call Vancouver home, as it is ... travel and picturesque journeys through the countryside. Vancouver hotel ...
(Date:7/13/2014)... additives are chemicals, which are added to various fuels ... on, in order to enhance their performance. Fuel additives ... by fuels and improving the combustion properties of fuels. ... scale in the long run, but, in the short ... products. , The various fuel additive types include deposit ...
(Date:7/13/2014)... Houston, TX (PRWEB) July 13, 2014 The ... for children ranging in age from four months to 12 ... skills and karate classes to birthday parties and Summer Camps, ... the Little Gym of Pearland after spending over ... variety of roles, including Gym Director. , Berry has ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Recently, MyDressCity.com, ... and women’s special occasion outfits, has released its new ... all the new products are available at discounted prices. ... 26, 2014. , In the company’s online shop, ... all of them are made with great materials. MyDressCity.com’s ...
Breaking Medicine News(10 mins):Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2
... temperatures could limit deaths from heat stroke, study says ... dry air under a football player,s uniform may prevent ... the cool air between a player and his pads ... to the findings, which are expected to be presented ...
... to Get More for Less, AUSTIN, Texas, July ... leading natural and organic foods supermarket,announced today the launch ... money-saving coupons and tips, and,budget recipes to help shoppers ... their food dollar. The Company has also,created a space ...
... July 10 SectorWatch.biz announces the,availability of MarketStats ... markets today. MarketStats offers a perspective on the,aforementioned ... with,articles and opinions on the subject and sector ... can view MarketStats by visiting: http://www.SectorWatch.biz ,-- ...
... 10 Reflecting the,continuing commitment of America,s ... and practices that best serve,the needs of ... and Manufacturers of America (PhRMA) Board of ... Code on Interactions with Healthcare,Professionals., The ...
... and PLANO, Texas, July 10 In the ... soon become heated with the,arrival of the newest ... market. Anika Therapeutics, FDA-approved ELEVESS(TM) enters the,arena with ... their,hyaluronic acid (H.A.) gel, to improve injection comfort., ...
... Bioniche Life Sciences,Inc. (TSX: BNC), a research-based, ... E. coli O157:H7,cattle vaccine at the XXV ... presentation was made by Dr. Dragan Rogan, ... was entitled,"Vaccination of Cattle with E. coli ...
Cached Medicine News:Health News:Cool Air Blown Under Pads May Protect Footballers From Illness 2Health News:Whole Foods Market(R) Launches 'The Real Deal' Program With Budget Recipes, Real Steals and Smart Shopping Advice 2Health News:Whole Foods Market(R) Launches 'The Real Deal' Program With Budget Recipes, Real Steals and Smart Shopping Advice 3Health News:SectorWatch.biz Issues MarketStats on Healthy Living Companies UKMA, LULU, GAIA, NTRI, and WTW 2Health News:PhRMA Revised Marketing Code Reinforces Commitment to Responsible Interactions With Healthcare Professionals 2Health News:PhRMA Revised Marketing Code Reinforces Commitment to Responsible Interactions With Healthcare Professionals 3Health News:PhRMA Revised Marketing Code Reinforces Commitment to Responsible Interactions With Healthcare Professionals 4Health News:Latest Hyaluronic Acid Filler Takes the Sting Out of Beauty 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary 3Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary 4
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... Finnpipette Digital offers improved ergonomics for ... handle, modified grippy finger rest and ... comfort and efficiency. Finnpipette Digitals also ... gearing mechanism (pat. pend.) and super ...
Research Series 2100 Adjustable-volume Pipette,100-1,000 l, single-channel with adjustable-volume setting...
... The Sysmex pocH-100i is the first ... with low daily testing requirements. With its ... 3-part differential from just 15 L of ... for any small healthcare site including the ...
Medicine Products: